# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Favipiravir | T-705 | EC50 | = | 24 | uM | ALA5255527 | 4.62 | nM | Zaire ebolavirus | ||
2. | ALA5279888 | 12 | EC50 | < | 0.1 | uM | ALA5255527 | nM | Zaire ebolavirus | |||
3. | Azithromycin | Azithromycin | EC50 | = | 5.1 | uM | ALA5246344 | 5.29 | nM | Zaire ebolavirus | ||
4. | LY294002 | 2 (LY-294002) | EC50 | = | 1.8 | uM | ALA5131849 | 5.75 | nM | Zaire ebolavirus | ||
5. | Vacuolin-1 | 62 | INH | = | 100 | % | ALA5131849 | % | Zaire ebolavirus | |||
6. | ALA4448515 | 3j; DABMA | EC50 | = | 908 | nM | ALA4307405 | 6.04 | nM | Zaire ebolavirus | ||
7. | ALA4448515 | 3j; DABMA | INH | > | 50 | % | ALA4307406 | % | Zaire ebolavirus | |||
8. | ALA4448515 | 3j; DABMA | Ratio EC50 | = | 6.6 | ALA4307409 | Zaire ebolavirus | |||||
9. | Favipiravir | T-705 | IC50 | = | 67 | uM | ALA4723125 | 4.17 | nM | Zaire ebolavirus | ||
10. | Favipiravir | T-705 | Activity | = | 100 | % | ALA4723124 | % | Zaire ebolavirus | |||
11. | ALA4279271 | 12 | IC50 | 0 | ALA4710518 | Not Active | Zaire ebolavirus | |||||
12. | ALA4277048 | 10 | IC50 | 0 | ALA4710518 | Not Active | Zaire ebolavirus | |||||
13. | ALA4276737 | 8 | IC50 | 0 | ALA4710518 | Not Active | Zaire ebolavirus | |||||
14. | ALA4792802 | 4b.HCl | IC50 | = | 64.7 | uM | ALA4710518 | 4.19 | nM | Zaire ebolavirus | ||
15. | ALA4288786 | 6 | IC50 | = | 54.3 | uM | ALA4710518 | 4.26 | nM | Zaire ebolavirus | ||
16. | ALA4759028 | 3b.HCl | IC50 | = | 9.1 | uM | ALA4710518 | 5.04 | nM | Zaire ebolavirus | ||
17. | ALA4278533 | 4 | IC50 | = | 47.5 | uM | ALA4710518 | 4.32 | nM | Zaire ebolavirus | ||
18. | ALA4760524 | 37 | IC50 | = | 0.74 | uM | ALA4670542 | 6.13 | nM | Zaire ebolavirus | ||
19. | ALA4742939 | 36 | IC50 | = | 0.35 | uM | ALA4670542 | 6.46 | nM | Zaire ebolavirus | ||
20. | ALA4751531 | 35 | IC50 | = | 0.006 | uM | ALA4670542 | 8.22 | nM | Zaire ebolavirus |